Seattle Genetics, Astellas snag bladder cancer OK for Padcev by Carly Helfand Wednesday, December 18, 2019 Wednesday, the FDA approved Padcev, a first-of-its kind antibody-drug conjugate. The product targets Nectin-4, a protein on the surface of cells.
